|This Slide: #30 of 100|
Slide #30. Concordia Healthcare Corp. — Pinnacle Biologics, Inc.
Concordia Healthcare Corp. (CXR.CA)
Pinnacle Biologics, Inc.
Concordia Healthcare Corp., an integrated, specialty healthcare company focused on the acquisition of legacy pharmaceutical products and medical devices and the acquisition and/or development of orphan drugs, announced today that it has acquired Pinnacle Biologics, Inc., a U.S.-based biopharmaceutical company specializing in legacy pharmaceuticals which have the potential for development as orphan drugs to treat cancer indications in addition to those for which they have previously been approved.
Concordia International is an integrated, specialty healthcare company focused on the acquisition of legacy pharmaceutical products, the acquisition and development of orphan drugs, and distribution of medical devices servicing the diabetic population.
Open the CXR.CA Page at The Online Investor »